Treatment of Patients with Hepatitis C Virus infection (Genotype 4) with Ledipasvir-Sofosbuvir in the liver transplant setting

被引：0
|
作者：
Abaalkhail, Faisal A. [1 ,2 ]
Elsiesy, Hussein A. [1 ,2 ]
Al Sebayel, Mohammed [1 ]
Aljedai, Ahmed [1 ]
Ajlan, Aziza A. [1 ]
Elbeshbeshy, Hany [1 ]
Al-Hamoudi, Waleed K. [1 ,3 ]
机构：
[1] King Faisal Specialist Hosp & Res Ctr, Riyadh, Saudi Arabia
[2] Alfaisal Univ, Riyadh, Saudi Arabia
[3] King Saud Univ, Riyadh, Saudi Arabia
来源：
HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1933
引用
收藏
页码：956A / 957A
页数：2
相关论文
共 50 条
  • [21] Sofosbuvir/ledipasvir as treatment of hepatitis C virus genotype 5 infection: Two case reports
    Chamorro-de-Vega, Esther
    Gimenez-Manzorro, Alvaro
    Sanjurjo, Maria
    MEDICINA CLINICA, 2018, 151 (02): : 85 - 86
  • [22] The Safety and Effectiveness of Ledipasvir-Sofosbuvir in Adolescents 12-17 Years Old With Hepatitis C Virus Genotype 1 Infection
    Balistreri, William F.
    Murray, Karen F.
    Rosenthal, Philip
    Bansal, Sanjay
    Lin, Chuan-Hao
    Kersey, Kathryn
    Massetto, Benedetta
    Zhu, Yanni
    Kanwar, Bittoo
    German, Polina
    Svarovskaia, Evguenia
    Brainard, Diana M.
    Wen, Jessica
    Gonzalez-Peralta, Regino P.
    Jonas, Maureen M.
    Schwarz, Kathleen
    HEPATOLOGY, 2017, 66 (02) : 371 - 378
  • [23] Successful Posttransplant Treatment of Hepatitis C With Ledipasvir-Sofosbuvir in HIV plus Kidney Transplant Recipients
    Sawinski, Deirdre
    Lee, Dong H.
    Doyle, Alden M.
    Blumberg, Emily A.
    TRANSPLANTATION, 2017, 101 (05) : 974 - 979
  • [24] Role of ledipasvir/sofosbuvir combination for genotype 1 hepatitis C virus infection
    Sundaram, Vinay
    Kowdley, Kris V.
    HEPATIC MEDICINE-EVIDENCE AND RESEARCH, 2016, 8 : 75 - 80
  • [25] The effectiveness and safety of sofosbuvir-ledipasvir for patients with hepatitis C virus genotype 2 infection
    Chen, Po-Yueh
    Yang, Hsin-Yi
    Chou, Chu-Kuang
    Chang, Li-Jen
    Hsu, Ming-Tse
    Tsai, Tsung-Jung
    Fang, Chien-Chung
    Su, Chang-Chao
    Lin, Yu-Ling
    Feng, Yu-Ming
    Chen, Chi-Yi
    ADVANCES IN DIGESTIVE MEDICINE, 2022, 9 (02) : 91 - 97
  • [26] Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic Response
    Terrault, Norah A.
    Zeuzem, Stefan
    Di Bisceglie, Adrian M.
    Lim, Joseph K.
    Pockros, Paul J.
    Frazier, Lynn M.
    Kuo, Alexander
    Lok, Anna S.
    Shiffman, Mitchell L.
    Ben Ari, Ziv
    Akushevich, Lucy
    Vainorius, Monika
    Sulkowski, Mark S.
    Fried, Michael W.
    Nelson, David R.
    GASTROENTEROLOGY, 2016, 151 (06) : 1131 - +
  • [27] Successful Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir and Ledipasvir in Renal Transplant Recipients
    Eisenberger, Ute
    Guberina, Hana
    Willuweit, Katharina
    Bienholz, Anja
    Kribben, Andreas
    Gerken, Guido
    Witzke, Oliver
    Herzer, Kerstin
    TRANSPLANTATION, 2017, 101 (05) : 980 - 986
  • [28] Generic Ledipasvir-Sofosbuvir Treatment for Adolescents With Chronic Hepatitis C Virus Infection (Jul, piz041, 2019)
    Fouad, H. M.
    Sabry, M. A.
    Ahmed, A.
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2019, 8 (06) : 586 - 586
  • [29] Ledipasvir/sofosbuvir without ribavirin is effective in the treatment of recurrent hepatitis C virus infection post-liver transplant
    Shoreibah, Mohamed
    Orr, Jordan
    Jones, DeAnn
    Zhang, Jie
    Venkata, Krishna
    Massoud, Omar
    HEPATOLOGY INTERNATIONAL, 2017, 11 (05) : 434 - 439
  • [30] Ledipasvir/sofosbuvir without ribavirin is effective in the treatment of recurrent hepatitis C virus infection post-liver transplant
    Mohamed Shoreibah
    Jordan Orr
    DeAnn Jones
    Jie Zhang
    Krishna Venkata
    Omar Massoud
    Hepatology International, 2017, 11 : 434 - 439
12345